News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
78,145 Results
Type
Article (2488)
Company Profile (22)
Press Release (75635)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (33079)
Career Advice (60)
Deals (4949)
Drug Delivery (5)
Drug Development (10718)
Employer Resources (10)
FDA (1719)
Job Trends (2280)
News (48562)
Policy (2947)
Tag
Academia (146)
Accelerated approval (5)
Allergies (19)
Alliances (2613)
ALS (40)
Alzheimer's disease (189)
Antibody-drug conjugate (ADC) (35)
Approvals (1808)
Artificial intelligence (32)
Autoimmune disease (21)
Automation (2)
Bankruptcy (20)
Best Places to Work (2179)
Biosimilars (10)
Biotechnology (11)
Bladder cancer (27)
Brain cancer (5)
Breast cancer (147)
Cancer (702)
Cardiovascular disease (58)
Career advice (55)
Career pathing (1)
CAR-T (13)
CDC (1)
Cell therapy (55)
Cervical cancer (8)
Clinical research (10107)
Collaboration (105)
Compensation (160)
Complete response letters (3)
COVID-19 (325)
CRISPR (5)
C-suite (29)
Cystic fibrosis (18)
Data (1151)
Depression (13)
Diabetes (52)
Diagnostics (850)
Digital health (4)
Diversity, equity & inclusion (3)
Drug discovery (17)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (29)
Earnings (30663)
Employer branding (2)
Employer resources (8)
Events (8141)
Executive appointments (27)
FDA (2277)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (6)
Funding (88)
Gene editing (11)
Generative AI (2)
Gene therapy (41)
GLP-1 (143)
Government (412)
Guidances (272)
Healthcare (2419)
HIV (12)
Huntington's disease (2)
IgA nephropathy (23)
Immunology and inflammation (33)
Immuno-oncology (2)
Indications (15)
Infectious disease (366)
Inflammatory bowel disease (32)
Inflation Reduction Act (1)
Influenza (18)
Intellectual property (15)
Interviews (8)
IPO (3560)
IRA (2)
Job creations (215)
Job search strategy (47)
Kidney cancer (3)
Labor market (18)
Layoffs (49)
Leadership (1)
Legal (437)
Liver cancer (7)
Longevity (3)
Lung cancer (145)
Lymphoma (78)
Machine learning (1)
Management (2)
Manufacturing (52)
MASH (39)
Medical device (1806)
Medtech (1811)
Mergers & acquisitions (1489)
Metabolic disorders (179)
Multiple sclerosis (46)
NASH (4)
Neurodegenerative disease (34)
Neuropsychiatric disorders (18)
Neuroscience (368)
NextGen: Class of 2026 (507)
Non-profit (413)
Now hiring (2)
Obesity (81)
Opinion (6)
Ovarian cancer (20)
Pain (25)
Pancreatic cancer (19)
Parkinson's disease (18)
Partnered (3)
Patents (27)
Patient recruitment (36)
Peanut (10)
People (2351)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase I (2107)
Phase II (4148)
Phase III (4463)
Pipeline (1504)
Policy (12)
Postmarket research (462)
Preclinical (679)
Press Release (2)
Prostate cancer (24)
Psychedelics (2)
Radiopharmaceuticals (27)
Rare diseases (80)
Real estate (321)
Recruiting (5)
Regulatory (2534)
Reports (8)
Research institute (181)
Resumes & cover letters (4)
Rett syndrome (2)
RNA editing (1)
RSV (12)
Schizophrenia (23)
Series A (6)
Series B (10)
Sickle cell disease (11)
Special edition (3)
Spinal muscular atrophy (10)
Sponsored (3)
Startups (135)
Stomach cancer (2)
Supply chain (1)
Tariffs (2)
The Weekly (2)
Vaccines (86)
Venture capital (11)
Weight loss (39)
Women's health (5)
Worklife (1)
Date
Today (16)
Last 7 days (60)
Last 30 days (208)
Last 365 days (5162)
2026 (60)
2025 (5142)
2024 (5482)
2023 (5967)
2022 (6930)
2021 (7305)
2020 (6468)
2019 (5112)
2018 (4070)
2017 (3616)
2016 (2702)
2015 (3646)
2014 (2403)
2013 (1632)
2012 (2188)
2011 (2376)
2010 (2146)
Location
Africa (51)
Alabama (17)
Arizona (24)
Arkansas (1)
Asia (3940)
Australia (398)
California (1616)
Canada (595)
China (150)
Colorado (86)
Connecticut (79)
Delaware (106)
Europe (10231)
Florida (209)
Georgia (56)
Idaho (6)
Illinois (98)
India (4)
Indiana (106)
Japan (88)
Kansas (11)
Kentucky (4)
Louisiana (7)
Maine (15)
Maryland (152)
Massachusetts (1224)
Michigan (40)
Minnesota (85)
Mississippi (1)
Missouri (15)
Montana (4)
Nebraska (2)
Nevada (12)
New Hampshire (9)
New Jersey (648)
New York (568)
North Carolina (184)
Northern California (903)
Ohio (36)
Oklahoma (1)
Oregon (4)
Pennsylvania (487)
Puerto Rico (1)
South America (102)
South Carolina (5)
Southern California (583)
Tennessee (14)
Texas (186)
United States (6214)
Utah (52)
Virginia (21)
Washington D.C. (17)
Washington State (159)
West Virginia (1)
Wisconsin (7)
78,145 Results for "48".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vizgen Announces $48 Million Financing
January 8, 2026
·
2 min read
Government
Despite mRNA Vaccine Pullback, HHS Awards $48M for Kernal’s mRNA CAR T Program
The $48 million award, granted through the Advanced Research Projects Agency for Health, will help Kernal take its in vivo mRNA-encoded CAR T therapy forward.
October 8, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
BioMarin Pumps Up Revenue Goals With $4.8B Amicus Purchase
BioMarin Pharmaceutical has faced a rocky road, promising and then backing off revenue targets and cutting assets that have underperformed. But Amicus’ rare disease portfolio is already bringing in $600 million annually.
December 19, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025
December 8, 2025
·
12 min read
Press Releases
Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial
December 22, 2025
·
9 min read
Press Releases
Infectious Disease In Vitro Diagnostics Market Set to Reach USD 31.48 Billion by 2034
November 10, 2025
·
1 min read
Press Releases
Single-use Bioprocessing Market Size to Surpass USD 151.48 Bn by 2034
October 30, 2025
·
1 min read
Press Releases
Ultomiris Drug Market Size to Hit USD 48.61 Billion by 2034, Growing at a Stellar 28.5% CAGR
November 24, 2025
·
1 min read
Press Releases
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
December 22, 2025
·
23 min read
Press Releases
bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering
September 29, 2025
·
4 min read
1 of 7,815
Next
